Nafithromycin: advancements in antibiotic therapy against community-acquired pneumonia-resistant pathogens

Nafithromycin (WCK 4873) is a novel lactone ketolide antibiotic developed to address the critical issue of multidrug-resistant bacteria, especially those causing community-acquired pneumonia (CAP). Given the increasing prevalence of antibiotic resistance, there is a pressing need for new antibiotic...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Akshata Gore, Agadi Hiremath Viswanatha Swamy, Sanatkumar Bharamu Nyamagoud
Formato:	Artigo
Idioma:	Inglês
Publicado em:	PAGEPress Publications 2025-08-01
coleção:	Monaldi Archives for Chest Disease
Assuntos:	Nafithromycin community-acquired pneumonia multidrug-resistant bacteria lactone ketolide antibiotic pharmacokinetics
Acesso em linha:	https://www.monaldi-archives.org/macd/article/view/3340
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!